- Blood Pressure and Diabetic Nephropathy
- Long-Term Effect of an Education Program (HyPOS) on the Incidence of Severe Hypoglycemia in Patients With Type 1 Diabetes
- Subclinical Hypothyroidism Is Associated With Reduced All-Cause Mortality in Patients With Type 2 Diabetes
- Serotonin 5-HT3 Receptor Antagonist for Treatment of Severe Diabetic Diarrhea
- Immunologic Tolerance to the Insulin Analogue Glulisine
Privacy Policy
Our Commitment To Your Privacy
Your privacy is important to us. To better protect your privacy we provide this notice explaining our online information practices and the choices you can make about the way your information is collected and used. To make this notice easy to find, we make it available on our homepage and at every point where personally identifiable information may be requested.
Our Commitment To Data Security
To prevent unauthorized access, maintain data accuracy, and ensure the correct use of information, we have put in place appropriate physical, electronic, and managerial procedures to safeguard and secure the information we collect online.
Our Commitment To Childrens Privacy
Protecting the privacy of the very young is especially important. For that reason, we never collect or maintain information at our website from those we actually know are under 18, and no part of our website is structured to attract anyone under 18. Under our Terms of Service, children under 18 are no allowed to access our service.
Collection of Personal Information
On visiting this site, the IP address used to access the site will be logged along with the dates and times of access. This information is purely used to analyse trends, administer the site, track users movement, and gather broad demographic information for aggregate use. Importantly, IP addresses are not linked to personally identifiable information.
Links to third party websites
We have included links on this site for your reference. We are not responsible for the privacy policies on these websites.
lterations to this Privacy Statement
The content of this statement may be altered at any time.
- Diamyd Medical: Diamyd US Phase III Study Well Under WayDiamyd Medical (STO:DIAMB)(Pink Sheets:DMYDY) announces today that one hundred study participants have been included in the ongoing US Phase III study, DiaPrevent. The global Phase III program with the company's lead drug candidate Diamyd® has thereby enrolled more than 430 children newly diagnosed with type 1 diabetes in Europe and the USA...
- Hepatitis C And Insulin Resistance - Surprising FindingsWe have known for several years that Hepatitis C, a common cause of liver cirrhosis and cancer, also makes people three to four times more likely to develop Type 2 diabetes. In studying the insulin resistance of 29 people with Hepatitis C, Australian researchers have confirmed that they have high insulin resistance, a precursor to diabetes...
- Starting Treatment Early Doubles Chance Of Success For People With DiabetesThe sooner people with diabetes start taking metformin, the longer the drug remains effective, according to a Kaiser Permanente study published in the March issue of Diabetes Care, a journal of the American Diabetes Association...
- Link Between Hepatitis C And Insulin Resistance Surprises ScientistsScientists in Australia found that when they studied insulin resistance in people with Hepatitis C little or none of it was in the liver and nearly all the insulin resistance occured in muscle, which surprised them because Hepatitis C is a liver disease that not only leads to cirrhosis and cancer, but also makes people three to four times more likely to d […]